Recruiting
Stress Reduction Through Acupuncture
This randomized controlled trial evaluates whether eight weeks of weekly acupuncture can reduce psychological distress in breast cancer patients who have recently completed primary therapy compared to standard-of-care wait-list control.
ClinicalTrials.gov IDNCT07132034
PhaseNA
Enrollment112
SponsorIsabell Xiang Ge
Age18 Years
SexFEMALE
Conditions studied
Acupuncture, Breast Cancer, Survivorship
About this study
This randomized controlled trial evaluates whether eight weeks of weekly acupuncture can reduce psychological distress in breast cancer patients who have recently completed primary therapy compared to standard-of-care wait-list control.
Interventions
- Procedure: Acupuncture — 8 sessions of acupuncture treatment (body and auricular acupuncture) will be given once a week after randomization.
- Other: Standard supportive care — Supportive care according to local standards will be given which may also include face-to-face psychosocial support or the participation of support groups
Primary outcomes
- Distress at 8 weeks of intervention (Post-intervention (after completion of the 8 week acupuncture therapy or SOC))
Eligibility information
Inclusion criteria:
* Patients with localized breast cancer having completed primary therapy (operation +/- chemotherapy +/- radiotherapy) in the last 6 months - Distress Thermometer ≥ 5 - Age ≥ 18 years - Signed informed consent for participation of the trial
* Prior cancer is allowed
* Prior treatment - including chemotherapy - for a prior malignant tumor (including breast cancer) is allowed
* Concomitant participation in an experimental therapeutic drug trial is allowed
* Ongoing or planned Anti-her2/neu, immune checkpoint inhibitor, antihormonal and CDK4/6 inhibitor therapy or other adjuvant treatment scheduled for \> 3 months during study period is allowed
* Use of other complementary methods (including mistletoe) is allowed.
Exclusion criteria:
* Patients with language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study
* Severe physical or psychiatric comorbidity that prevents a patient from participating in the study
* Patients incapable of giving consent
* Pregnancy
Study locations
- University Hospital Basel, Basel, 4031 Switzerland
- Gesundheitszentrum Fricktal AG Frauenklinik, Rheinfelden, Switzerland
- Onkologie- & Hämatologiezentrums, Spital STS AG Thun, Thun, Switzerland
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.